Approvals and New Uses
The original application and every efficacy supplement, newest first; all 11 submissions below| Date | Submission | Status | Documents |
|---|
| Mar 28, 2005 | Original application | Approved | None posted |
Products
3 strengths and formsAll 11 submissions, including labeling and manufacturing supplements
| Date | Submission | Status | Documents |
|---|
| May 26, 2022 | Supplement 18Labeling · Standard review | Approved | None posted |
| May 26, 2022 | Supplement 19Labeling · Standard review | Approved | None posted |
| May 26, 2022 | Supplement 20Labeling · Standard review | Approved | None posted |
| May 26, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Feb 16, 2016 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 24, 2015 | Supplement 10Labeling · Standard review | Approved | None posted |
| Apr 24, 2015 | Supplement 11Labeling · Standard review | Approved | None posted |
| Apr 24, 2015 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 24, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jan 10, 2011 | Supplement 8Labeling | Approved | None posted |
| Mar 28, 2005 | Original application | Approved | None posted |
Identifiers
- Application
- ANDA 77093
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters